Qualitek Labs Limited announced significant corporate developments following its board meeting held on December 20, 2025, at the company's corporate office in Noida. The board approved several key proposals related to fundraising through debt instruments and associated corporate actions.

Non-Convertible Debentures Issuance Approved

The board approved the proposal for issuance and allotment of secured, unlisted, redeemable non-convertible debentures (NCDs) through private placement. The key parameters of the proposed NCD issuance are outlined below:

The issuance remains subject to receipt of necessary statutory, regulatory, and shareholder approvals as applicable. The tenure, date of allotment, and maturity date will be determined at the time of allotment in accordance with final terms approved by the board and agreed with the debenture trustee.

Debenture Trustee Appointment

The board approved the appointment of Vistra ITCL (India) Limited as the debenture trustee in connection with the proposed NCD issuance. The debenture trustee will oversee the interests of debenture holders and ensure compliance with the terms and conditions of the issue.

Security Structure and Guarantees

To secure the proposed NCDs, the board approved the creation of comprehensive security interests and furnishing of guarantees. The security structure includes multiple layers of protection:

These security arrangements will be finalized in accordance with terms agreed with the debenture trustee and subject to receipt of applicable approvals, including shareholder approval under Section 180(1)(a) of the Companies Act, 2013.

Extraordinary General Meeting

The board approved convening an Extraordinary General Meeting (EGM) of shareholders to seek approval for critical matters related to the NCD issuance. The EGM will address creation of security over company assets pursuant to Section 180(1)(a) of the Companies Act, 2013, and approval of material related party transactions, if any, in accordance with applicable provisions of SEBI LODR Regulations and the Companies Act, 2013.

The specific date, time, and venue of the EGM will be communicated separately in due course. The board meeting commenced at 11:30 AM and concluded at 12:45 PM on December 20, 2025.

Qualitek Labs Limited announced the outcome of its board meeting held on December 10, 2025, where directors approved substantial credit facility arrangements with leading banks. The decisions were communicated to the Bombay Stock Exchange on December 11, 2025, in compliance with SEBI listing regulations.

Major Credit Facility Approvals

The board approved aggregate credit facilities totaling ₹80.31 crores from two prominent banks for working capital and other corporate purposes. The facilities are structured to provide the company with enhanced financial flexibility for its operations.

Corporate Guarantee and Security Arrangements

The board specifically approved a corporate guarantee arrangement with HDFC Bank Limited worth ₹30.70 crores. This approval includes provisions for creating charges over company assets to secure the credit facility repayment.

Security Framework

The security arrangements encompass multiple components designed to protect the lenders' interests:

• Corporate guarantee provision by Qualitek Labs Limited
• Creation of charges on company assets
• Mortgage arrangements on immovable properties
• Execution of deeds of guarantee and hypothecation agreements
• Related documentation as required by the banks

Regulatory Compliance and Documentation

The company confirmed that both credit facility arrangements do not constitute related party transactions. The facilities were sanctioned based on standard banking terms and conditions, with comprehensive security creation requirements.

Strategic Financial Positioning

These credit facilities represent a significant enhancement to Qualitek Labs' financial capabilities. The arrangements with established banking partners like HDFC Bank and Kotak Mahindra Bank provide the company with substantial working capital support and operational flexibility.

The board meeting, chaired by Managing Director Antaryami Nayak, concluded with all necessary approvals in place. The company has made complete disclosures available on its website in accordance with regulatory requirements, ensuring transparency for all stakeholders.